Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate
- 1 August 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (4), 231-237
- https://doi.org/10.1016/0002-9149(87)90219-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.Circulation, 1984
- Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.Circulation, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Intracoronary streptokinase in clinical practiceAmerican Heart Journal, 1982
- Effects of intracoronary streptokinase in acute myocardial infarctionAmerican Heart Journal, 1981
- Coronary Vasospasm as a Possible Cause of Myocardial InfarctionNew England Journal of Medicine, 1978
- A Table of Exact Confidence Limits for Differences and Ratios of Two Proportions and Their Odds RatiosJournal of the American Statistical Association, 1977